The assessment of the regenerative capacity of the heart has been compromised by 31 the lack of surface signatures to characterize cardiomyocytes. Here, combined 32 multiparametric surface marker analysis with single cell transcriptional profiling and in 33 vivo transplantation, identify the main fetal cardiac populations and their progenitors.
Introduction

45
The cell types that form the mammalian heart have diverse developmental origins 46 and temporal differentiation 1 . In the mouse, cardiomyocytes (CMs) are initially 47 specified by embryonic day (E) 7.5 from the first set of cardiogenic progenitors (first
142
To probe the homogeneity of the cardiac subsets here defined we carried out 143 single-cell transcriptional analyses ( Supplementary Fig. 2a-b ). Cell sorting was 144 performed using the index-sorting tool that records, for each cell, the levels of 145 expression of each phenotypic parameter ( Supplementary Fig. 2c ). Both the heat-146 map and the PCA analysis indicated that the phenotypically defined populations 147 homogeneously co-expressed the analyzed transcripts, underscoring the strength of 148 this combined approach (Supplementary Fig. 2a-b ).
149
The ensemble of these results validated a phenotyping strategy ( Fig. 1; 150 Supplementary Table 1 ) that allowed the identification ( Fig. 2a-b ) and the prospective 151 isolation of the major cardiac cell subsets in the fetal heart ( Fig. 3g ). were detected in all analyzed embryonic stages. However, by E17.5 most Vt, but not 160 At, HSA + CMs had lost ALCAM expression ( Supplementary Fig. 3a ).
161
HSA + MCAM + (ALCAM -) and HSA + (MCAM -ALCAM -) CMs were more frequent in the 162 E17.5 Vt ( Supplementary Fig. 3a , bottom right plot) and triple negative CMs (HSA -163 MCAM -ALCAM -), initially detected in the E13.5 Vt, increased to comprise most CMs at 164 E17.5 ( Fig. 4a, d; Supplementary Fig. 3a, c, d) . Cell cycle analysis showed that E9.5 165 HSA + cells, with a transcriptional profile of CM PRGs (Fig.4b ), were highly 166 proliferative (63.7% in G1 and 15.9% in S/G2-M). As development proceeded, the 167 frequency of HSA + cells decreased, and they also divided less (14.4% versus 7.66% 168 were in S/G2-M at E13.5 and E17.5, respectively, Supplementary Fig. 3b ).
169
To investigate whether the phenotypically distinct CM subsets corresponded to 170 different stages of maturation, we included Tnnt 23 and Cav3 12 in our analysis. Surface
171
Cav3 expression is detected in the adult, but undetectable in most immature CMs 12 , 172 while Tnnt is widely expressed in the CM lineage 23, 24 . The transcriptional profile of the 173 HSA + CMs along time (E9.5, E13.5 and E17.5) revealed that Cav3 starts to be 174 transcribed at E9.5 ( Fig. 4b ), suggesting a lineage relationship between the two CM 175 subsets. These results highlight the progressive loss of the surface markers ALCAM,
176
MCAM and HSA coinciding with the transcriptional expression of Cav3 at E13.5, while 177 at E17.5 the majority of CMs (Tnnt + ) were HSA -MCAM -ALCAM -Cav3 + (Fig. 4a-b ).
178
During maturation, CMs lose proliferative capacity and suffer morphological 179 alterations leading to increased sarcomere complexity, bigger cell size and 180 binucleation 9 . Cell cycle analysis of E17.5 CM subsets (HSA + and Cav3 + ) showed that 181 HSA + cells were still proliferative (At: 24.4% and 20.5%; and Vt: 35.5% and 25.3%, in 182 G 1 and S/G 2 -M, respectively) whereas Cav3 + CMs were largely out of cycle (At 69.4%
183
and Vt 78% in G 0 , Supplementary Fig. 3c ). The stromal subsets were highly 184 proliferative (At: 36.6% and 11.2%; and Vt: 27.6% and 11.3%, respectively in G 1 and 185 S/G 2 -M, Supplementary Fig. 3c ). Binucleated cells (4N DNA) were observed in the 
199
Because HSA is the last surface protein to be lost before the acquisition of Cav3,
200
we used these two markers to discriminate immature and mature CMs, respectively.
201
Interestingly, HSA and Cav3 expression define two CMs subsets with different 202 proliferative capacity, even after birth. Three EdU (P0, P1 and P2) injections in the 203 neonates labeled 23% of HSA + CMs detected at P2 and 16% at P4, indicating that 204 this CM subset maintains proliferative activity after birth ( Fig. 4c ). By contrast, only 205 7% of Cav3 + CMs incorporated EdU, demonstrating a lower contribution of the mature 206 CM subset to postnatal heart growth ( Fig. 4c ). Other non-CM (stromal) cells showed 207 more than 50% EdU incorporation, compatible with their high proliferative activity at 208 this stage (Fig. 4c ). The reduced frequency of Cav3 + CMs at P7 detected by flow 209 cytometry ( Supplementary Fig. 3d , contour plots) reflects the sensitivity of postnatal 210 CMs to enzymatic digestion. To overcome this, we performed a similar analysis in 211 cells fixed before dissociation. Kinetics of HSA and Cav3 expression showed that the 212 decrease of the former parallels an increase of the latter ( Fig. 4d ). At E13.5 we 213 detected HSA+ (27.3% ± 3.3%), HSA + Cav3 + (10.3% ± 1.2%) and a few larger cells 214 expressing Cav3 (10.3% ± 2.6%). At E17.5, the majority of the cells expressed Cav3 215 (44.8% ± 6.3%), a fraction of them were binucleated (4.1% ± 0.9%) and coexisted 216 with smaller cells that were either HSA + (4.9% ±1.5%) or HSA + Cav3 + (3.9% ±1.9%).
9
After birth (P7), the majority of cells expressed Cav3 (53.1% ± 5.1%) and presented 218 two (2 nuclei, 38.7% ± 2.5%, *, Fig. 4d ) or more (>2 nuclei, 2.5% ± 0%, Fig. 4d ) 219 nuclei. CMs fixed prior to isolation were also analyzed by imaging flow cytometry, 220 evidencing decreased percentage of immature HSA + CMs during development (57.8% 221 ± 11.3% at E13.5 and 38.3% ± 3.8% at E17.5) with a pronounced decline after birth 222 (4.8% ± 2.3% at P7, Fig. 4e ). Importantly, HSA expression was only observed in 223 mononucleated CMs, further associating its expression with an immature phenotype 224 ( Fig. 4e ).
225
To confirm that HSA discriminates immature renewing CM, purified HSA + cells 226 isolated from E15.5, P2 or P4 and adult (< 4 weeks old) hearts were cultured for up to 227 one week. E15.5 HSA + cells either divided (~20%) or were contractile (~75%) in 228 culture, whereas no proliferation was observed in P2 or P4 cardiac cells, probably due 229 to the rapid differentiation in culture, ( Fig. 4f ; Supplementary Fig. 5a ; Supplementary   230 Movie 1). Seeded P2 and P4 cells adhered and were contractile at a frequency 231 ranging from 1:30-1:40 ( Supplementary Fig. 5b ), by contrast Cav3 + cells, irrespective 232 of the stage at which they were isolated, did not adhere to gelatin-coated plates and 233 were not viable after 3 days in culture (<1:1000). All P2 and P4 adherent cells showed 234 contractility ( Supplementary Fig. 5b ; Supplementary Movies 3, 4) whereas adult cells 235 adhered to gelatin-coated plates, survived for a few days and expressed troponin T, 236 but failed to contract ( Supplementary Fig 5c) . The non-organized pattern of troponin T 237 observed on contractile HSA + CMs in culture reflects their immaturity ( Fig. 4f ) and is a 238 feature also observed during development ( Fig. 4e ).
239
To show that immature CMs have the capacity to integrate cardiac tissue in vivo 240 we used a previously described experimental model 26 , where cardiac cells are 241 transplanted in an ectopic heart tissue previously implanted in the ear-pinna of adult 242 mice ( Supplementary Fig. 6a ). Viable functional implants were identified by 243 autonomous beating ascertained by visual inspection and by the presence of Ki67 + 244 mitotic cells ( Supplementary Fig 6b) . Seven days later, we transplanted either HSA + 245 CMs or cardiac stromal cells from Ubiquitin-GFP E15.5 embryos, as control 246 ( Supplementary Fig. 6a ). One week after transplantation, the implants injected with 247 HSA + GFP + CMs displayed regions of GFP + cells with the characteristic striated 248 pattern of myocytes, that also co-expressed troponin T ( Fig. 4g ). Together, these 249 results demonstrated the in vivo ability of immature HSA + CMs to engraft cardiac 250 tissue and maintain viability for up to one week.
251
Overall, our results identify distinct stages of CM maturation along development 252 based on surface marker expression. We defined two major CMs subsets: an 262 Supplementary Fig. 7b ). Imaging flow cytometry analysis further confirmed a discrete 263 subset of HSA + Actinin + CMs in adult hearts (0.6% ± 0.33%, n=3) and showed HSA 264 expression restricted to mononucleated CMs smaller (in area and length) than HSA -265 CMs (Fig. 5b ). The HSA + subset was considered as the most immature adult CMs 266 because they shared cytological and phenotypic properties with embryonic CMs, 267 although the majority also co-expressed the mature marker Cav3. Two stromal 268 populations were also discriminated in the adult: i) a PDGFrα + Sca-1 + Thy1 low subset of 269 interstitial FBs compatible with a previously described stromal population 27 and ii)
270
ICAM-1 + Gp38 + Thy1 + cells, expressing Gata4, Tek, Dcn, Twist1 and Tbx18 and 271 located in the sub-epicardial region ( Supplementary Fig. 7b , c). c-kit expression 272 previously associated with CM PRGs was exclusively found in adult PECAM-1 + ECs 273 and transcripts were also detected in ICAM-1 + sub-EpiCs ( Supplementary Fig. 7a-b ).
The detection of an immature CM subset in the adult prompted us to investigate 275 its frequency in the diseased heart. We found HSA expression largely circumscribed 276 to the non-CM compartment in sham-operated hearts, although rare 277 HSA + Actinin + CMs were also detected (outlined by laminin expression, Fig. 5c ). Seven 278 days after MI, and in spite of HSA expression associated to the upsurge of the 279 hematopoietic and endothelial cells ( Supplementary Fig. 7d ), we detected a three-fold 280 increase in the frequency of HSA + small round and large striated mononucleated CMs 281 (#) (4.7% ± 3.6%, *) compared to sham-operated (1.7% ±1.1%, Fig. 5c ). HSA + CMs 282 were found in the peri-infarcted region as shown in the lower magnification image 283 ( Fig. 5c ). Moreover, a small percentage of HSA + CMs (i.e. approximately one per 284 section) were in cycle (Ki67 expression) after MI. A similar increase in HSA + CMs was 285 evidenced after MI by imaging flow cytometry analysis of pre-fixed cells (1.8% ± 286 0.3%), when compared to sham-operated hearts (0.6% ± 0.15%, Fig. 5d ).
287
Our results show that the cell surface signatures defined for the embryonic heart 
325
We identified HSA, so far never associated to heart development or maturation, 326 as a transversal marker of immature CMs throughout life. Our analysis showed a 327 continuum in CM maturation, which is an asynchronous process that starts during 328 development and can be prospectively identified by the expression of distinct surface 329 markers (Fig. 6 ). Immature CMs can be identified by a unique phenotype, i.e. 
359
Although HSA + immature CMs do not proliferate sufficiently to regenerate the 360 myocardium, they might account for the low CM turnover rate previously described in 361 the adult 21,22,39 and be more amenable than binucleated CMs to respond to mitotic 362 stimuli. Importantly, using the strategy herein described, CMs at different maturation 363 stages can now be prospectively isolated as viable cells from the adult heart, 364 enabling further mechanistic studies.
365
METHODS
366
Mice. C57BL/6 mice (Charles River) 6 -8 week-old or timed pregnant females were 367 used. Timed-pregnancies were generated after overnight mating. The following 368 morning, females with vaginal plug were considered to be at E0.5.
369
All animal manipulations at i3S were approved by the Animal Ethics Committee and 
378
Transplantation of Ubiquitin-GFP cells in embryonic cardiac implants (ear-pinna 379 model). As shown in Supplementary Fig. 6a, E15 .5 cardiac Vt from wild-type (WT) 380 embryos were dissected and grafted in the ear-pinna of a recipient adult WT mice, 381 under anesthesia, as previously described 26 . Seven days later, E15.5 hearts from 382 Ubiquitin-GFP mice were dissociated and HSA+ immature CMs or PDGFrα+ fibroblasts 383 (stromal cells) were sorted and directly injected into visible beating implants (10 000 384 cells per implant). One week later, the implants were collected and tissue was 385 processed for immunofluorescence as described below. 
415
Whenever using a non-conjugated antibody, a sequential incubation with a secondary 416 antibody was performed 15 minutes 4ºC in the dark (see Supplementary Table 2 for the 417 antibodies list). Propidium iodide (PI, 1µg/ml) was used to exclude dead cells.
418
Intracellular proteins detection was performed after surface staining, fixation and 419 permeabilization with the Foxp3/Transcription Factor Staining Buffer Set (eBioscience).
420
DAPI was used to stain DNA in fixed cells (5 minutes at 4ºC). Flow cytometry data was acquired in a BD FACSCanto™ II and in a Sony SP6800 analyser (Sony) and analysed 422 with the FlowJo v10.0.8 (Treestar), Kaluza 1.5 (Beckman Coulter) or R v3.2.4 software.
423
Cells were sorted in a BD FACSAria™ III directly into 96-well plates loaded with RT- Supplementary Fig. 2c ). Data were analysed with the FlowJo Supplementary Fig. 1 ). Marker Supplementary Fig. 1 ). Differential expressed genes among clusters assign a cell type to each 709 surface signature. Statistical significance was determine using two-way ANOVA test; p=0.007, q=0.01 710 (Table 1) 
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Color-code as in Supplementary Fig. 1 
